Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - rosuvastatin calcium -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - rosuvastatin calcium -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - rosuvastatin calcium -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - atenolol -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - allopurinol -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - allopurinol -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - allopurinol -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - allopurinol -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - atenolol, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; pregelatinised maize starch; hypromellose; colloidal anhydrous silica; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; titanium dioxide; indigo carmine; methylcellulose; macrogol 400 - atenolol is indicated in the management of: 1. all grades of hypertension, including hypertension of renal origin. 2. frequent disabling angina without evidence of cardiac failure. 3. cardiac arrhythmias (maintenance treatment of supraventricular and ventricular arrhythmias, including those associated with acute myocardial infarction). 4. myocardial infarction: late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain).

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - doxycycline -